Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea
CONCLUSIONS: Our study found a significant difference between the performance of MELD-3.0 and MELD-Na in Korean patients with LC.PMID:38296843 | DOI:10.3904/kjim.2023.005
Source: The Korean Journal of Internal Medicine - Category: Internal Medicine Authors: Jeong Han Kim Yong Joon Cho Won Hyeok Choe So Young Kwon Byung-Chul Yoo Source Type: research
More News: Cirrhosis | Internal Medicine | Liver | Liver Disease | Liver Transplant | Sodium | Study | Transplants | Urology & Nephrology